Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance

Figure 3 Percentage of hepatocelllular carcinoma onset by the age-male-albumin-bilirubin-platelets score at follow-up 12. No patients develop cancer during the follow-up period in the low-risk group of patients with age-male-albumin-bilirubin-platelets scores < 50. Carcinogenesis is seen in 1.7% of patients in the medium-risk group, with scores of 50-59, and 8.3% of patients in the high-risk group, with scores ≥ 60.